213 related articles for article (PubMed ID: 26672895)
1. Ipilmumab and cranial radiation in metastatic melanoma patients: a case series and review.
Schoenfeld JD; Mahadevan A; Floyd SR; Dyer MA; Catalano PJ; Alexander BM; McDermott DF; Kaplan ID
J Immunother Cancer; 2015; 3():50. PubMed ID: 26672895
[TBL] [Abstract][Full Text] [Related]
2. A systematic evaluation of abscopal responses following radiotherapy in patients with metastatic melanoma treated with ipilimumab.
Chandra RA; Wilhite TJ; Balboni TA; Alexander BM; Spektor A; Ott PA; Ng AK; Hodi FS; Schoenfeld JD
Oncoimmunology; 2015 Nov; 4(11):e1046028. PubMed ID: 26451318
[TBL] [Abstract][Full Text] [Related]
3. Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.
Jones PS; Cahill DP; Brastianos PK; Flaherty KT; Curry WT
Neurosurg Focus; 2015 Mar; 38(3):E5. PubMed ID: 25727227
[TBL] [Abstract][Full Text] [Related]
4. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
[TBL] [Abstract][Full Text] [Related]
5. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery.
Mathew M; Tam M; Ott PA; Pavlick AC; Rush SC; Donahue BR; Golfinos JG; Parker EC; Huang PP; Narayana A
Melanoma Res; 2013 Jun; 23(3):191-5. PubMed ID: 23462208
[TBL] [Abstract][Full Text] [Related]
6. Outcomes and toxicity of stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab.
Olson AC; Thomas S; Qin R; Singh B; Salama JK; Kirkpatrick J; Salama AK
Melanoma Manag; 2016 Sep; 3(3):177-186. PubMed ID: 30190887
[TBL] [Abstract][Full Text] [Related]
7. Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review.
Chicas-Sett R; Morales-Orue I; Rodriguez-Abreu D; Lara-Jimenez P
Clin Transl Radiat Oncol; 2018 Feb; 9():5-11. PubMed ID: 29594244
[TBL] [Abstract][Full Text] [Related]
8. Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.
Grimaldi AM; Simeone E; Giannarelli D; Muto P; Falivene S; Borzillo V; Giugliano FM; Sandomenico F; Petrillo A; Curvietto M; Esposito A; Paone M; Palla M; Palmieri G; Caracò C; Ciliberto G; Mozzillo N; Ascierto PA
Oncoimmunology; 2014; 3():e28780. PubMed ID: 25083318
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiation therapy and immunotherapy.
Khalife M; Shahid K; Dabney RS; Phan AT
Clin Adv Hematol Oncol; 2019 Sep; 17(9):518-523. PubMed ID: 31549973
[TBL] [Abstract][Full Text] [Related]
10. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
[TBL] [Abstract][Full Text] [Related]
11. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).
Samlowski WE; Watson GA; Wang M; Rao G; Klimo P; Boucher K; Shrieve DC; Jensen RL
Cancer; 2007 May; 109(9):1855-62. PubMed ID: 17351953
[TBL] [Abstract][Full Text] [Related]
12. The abscopal effect: systematic review in patients with brain and spine metastases.
Pangal DJ; Yarovinsky B; Cardinal T; Cote DJ; Ruzevick J; Attenello FJ; Chang EL; Ye J; Neman J; Chow F; Zada G
Neurooncol Adv; 2022; 4(1):vdac132. PubMed ID: 36199973
[TBL] [Abstract][Full Text] [Related]
13. Radiation necrosis of the brain in melanoma patients successfully treated with ipilimumab, three case studies.
Du Four S; Wilgenhof S; Duerinck J; Michotte A; Van Binst A; De Ridder M; Neyns B
Eur J Cancer; 2012 Nov; 48(16):3045-51. PubMed ID: 22727601
[TBL] [Abstract][Full Text] [Related]
14. Stereotactic radiosurgery for patients with "radioresistant" brain metastases.
Brown PD; Brown CA; Pollock BE; Gorman DA; Foote RL
Neurosurgery; 2002 Sep; 51(3):656-65; discussion 665-7. PubMed ID: 12188943
[TBL] [Abstract][Full Text] [Related]
15. Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up.
Gutkin PM; Hiniker SM; Swetter SM; Reddy SA; Knox SJ
Cureus; 2018 Dec; 10(12):e3723. PubMed ID: 30788205
[TBL] [Abstract][Full Text] [Related]
16. Outcome predictors of Gamma Knife surgery for melanoma brain metastases. Clinical article.
Liew DN; Kano H; Kondziolka D; Mathieu D; Niranjan A; Flickinger JC; Kirkwood JM; Tarhini A; Moschos S; Lunsford LD
J Neurosurg; 2011 Mar; 114(3):769-79. PubMed ID: 20524829
[TBL] [Abstract][Full Text] [Related]
17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic radiosurgery for intraventricular brain metastases.
Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
[TBL] [Abstract][Full Text] [Related]
19. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment.
Ly D; Bagshaw HP; Anker CJ; Tward JD; Grossmann KF; Jensen RL; Shrieve DC
J Neurosurg; 2015 Aug; 123(2):395-401. PubMed ID: 25768829
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery boost to the resection bed for oligometastatic brain disease: challenging the tradition of adjuvant whole-brain radiotherapy.
Karlovits BJ; Quigley MR; Karlovits SM; Miller L; Johnson M; Gayou O; Fuhrer R
Neurosurg Focus; 2009 Dec; 27(6):E7. PubMed ID: 19951060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
